Picture of Acadia Pharmaceuticals logo

ACAD Acadia Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Acadia Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary

* ACADIA Pharmaceuticals Inc  ACAD.OQ  reported quarterly
adjusted
earnings of 20 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of 1 cents.  The mean expectation of
twenty analysts for the quarter was for earnings of 18 cents per
share. Wall Street expected results to range from 9 cents to 27
cents per share.
    * Revenue rose 46.4% to $241.96 million from a year ago;
analysts
expected $235.66 million. 
    * ACADIA Pharmaceuticals Inc's reported EPS for the quarter
was 20
cents​.
    * The company reported quarterly net income of $33.39
million.
    * ACADIA Pharmaceuticals Inc shares had risen by 13.3% this
quarter and lost 41.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 8.2%
in the last three months.​ 
    * In the last 30 days, five analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for ACADIA
Pharmaceuticals Inc is $28.00 
This summary was machine generated from LSEG data August 6 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.18           0.20           Beat
 Mar. 31 2024      0.05           0.10           Beat
 Dec. 31 2023      0.30           0.28           Missed
 Sep. 30 2023      -0.43          -0.40          Beat

Recent news on Acadia Pharmaceuticals

See all news